Slate Path Capital LP
- SEC CIK
- 0001559706
- Latest filing
- Aug 14, 2026
TEVA holding history
Teva Pharmaceutical Industries Ltd in every 13F filed by Slate Path Capital LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TEVA overviewAll 13F holders of TEVAFull Q2 2026 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −7,927,998−100.0% | Sold out | Holders |
| Q3 2025 | 7,927,998 | $160.1M | 2.5% | −362,000−4.4% | Reduced | Holders |
| Q2 2025 | 8,289,998 | $138.9M | 2.4% | −1,366,000−14.1% | Reduced | Holders |
| Q1 2025 | 9,655,998 | $148.4M | 2.7% | +1,164,965+13.7% | Added | Holders |
| Q4 2024 | 8,491,033 | $187.1M | 3.4% | −5,177,200−37.9% | Reduced | Holders |
| Q3 2024 | 13,668,233 | $246.3M | 4.1% | −6,522,951−32.3% | Reduced | Holders |
| Q2 2024 | 20,191,184 | $328.1M | 6.6% | −6,705,000−24.9% | Reduced | Holders |
| Q1 2024 | 26,896,184 | $379.5M | 7.5% | +665,000+2.5% | Added | Holders |
| Q4 2023 | 26,231,184 | $273.9M | 6.1% | +2,387,184+10.0% | Added | Holders |
| Q3 2023 | 23,844,000 | $243.2M | 6.8% | +11,407,000+91.7% | Added | Holders |
| Q2 2023 | 12,437,000 | $93.7M | 3.4% | +12,437,000 | New | Holders |